Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells

[1]  M. De Allegri,et al.  Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studies , 2014, BMC Public Health.

[2]  F. Powrie,et al.  Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model , 2013, The Journal of experimental medicine.

[3]  R. Locksley,et al.  Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.

[4]  C. Datz,et al.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.

[5]  F. Powrie,et al.  Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation , 2012, The Journal of experimental medicine.

[6]  T. Mcclanahan,et al.  IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells , 2012, Nature Medicine.

[7]  W. Ouyang,et al.  Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice , 2011, Mucosal Immunology.

[8]  F. Jirik,et al.  Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice. , 2011, The Journal of clinical investigation.

[9]  R. Pierce,et al.  IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass , 2011, The Journal of Immunology.

[10]  S. Travis,et al.  IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.

[11]  B. Becher,et al.  IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46 , 2010, Nature Immunology.

[12]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[13]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[14]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[15]  F. Powrie,et al.  Innate lymphoid cells drive IL-23 dependent innate intestinal pathology , 2010, Nature.

[16]  P. Munkholm,et al.  Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies , 2010, The American Journal of Gastroenterology.

[17]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[18]  S. Gaffen,et al.  Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in disease , 2010, Immunology.

[19]  Cynthia L Sears,et al.  A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.

[20]  L. Augenlicht,et al.  Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells; a crosstalk interrupted by vitamin D3 , 2009, Oncogene.

[21]  P. Kosmidis,et al.  Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. , 2009, Anticancer research.

[22]  V. Kuchroo,et al.  Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells1 , 2009, The Journal of Immunology.

[23]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[24]  G. Bhagat,et al.  Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. , 2008, Cancer cell.

[25]  M. Oft,et al.  Cytokine-based transformation of immune surveillance into tumor-promoting inflammation , 2008, Oncogene.

[26]  K. Maloy,et al.  IL-23 and Th17 cytokines in intestinal homeostasis , 2008, Mucosal Immunology.

[27]  J. Karras,et al.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, The Journal of clinical investigation.

[28]  S. Sa,et al.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.

[29]  N. Mukaida,et al.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. , 2008, The Journal of clinical investigation.

[30]  S. Itzkowitz,et al.  Cancer in inflammatory bowel disease. , 2008, World journal of gastroenterology.

[31]  T. Mak,et al.  TNF-α is critical for antitumor but not antiviral T cell immunity in mice , 2007 .

[32]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[33]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[34]  T. Mcclanahan,et al.  IL-23 promotes tumour incidence and growth , 2006, Nature.

[35]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[36]  P. Munkholm.  Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[37]  J. Kleibeuker,et al.  Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas , 2003, The Lancet.

[38]  T. Mcclanahan,et al.  A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.

[39]  J. Ward,et al.  IL-6 transgenic mouse model for extraosseous plasmacytoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Leach,et al.  Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death , 2001, The Journal of Immunology.

[41]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[42]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[43]  T. Mak,et al.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. , 2007, The Journal of clinical investigation.

[44]  R. Kastelein,et al.  Understanding the IL-23-IL-17 immune pathway. , 2006, Trends in immunology.

[45]  J. Baron,et al.  Nonsteroidal anti-inflammatory drugs and cancer prevention. , 2000, Annual review of medicine.